Prostate Adenocarcinoma With Neuroendocrine Differentiation
specificAn invasive prostate adenocarcinoma characterized by the presence of malignant cells that exhibit neuroendocrine differentiation.
11
Centers
11
Active Trials
—
Cancer Funding
Top Centers for Prostate Adenocarcinoma With Neuroendocrine Differentiation(11)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 54.5 |
| 2 | Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive Active Research Program | 54.5 |
| 3 | UC San Diego Moores Cancer CenterLa Jolla, CA NCI Comprehensive Active Research Program | 54.5 |
| 4 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 54.5 |
| 5 | Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program | 54.5 |
| 6 | UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive Active Research Program | 54.5 |
| 7 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 54.5 |
| 8 | VCU Massey Comprehensive Cancer CenterRichmond, VA NCI Comprehensive Active Research Program | 54.5 |
| 9 | Boston University Cancer CenterBoston, MA Active Research Program | 54.5 |
| 10 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive Active Research Program | 54.5 |
| 11 | Active Research Program | 54.5 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →